TB-500 × NextGen Peptides - Lab Test, February 2026
Test results
About this test
Thymosin Beta-4 23.8mg from NextGen Peptides achieves 99.107% purity according to this independent HPLC analysis with UV detection coupled to mass spectrometry. The test was conducted by Freedom Diagnostics Testing on February 27, 2026.
Thymosin Beta-4 is a peptide researched for tissue repair, wound healing, and musculoskeletal recovery. A purity level of 99.107% demonstrates pharmaceutical-grade synthesis with minimal contamination and high product consistency.
The certificate of analysis (COA #2602040216) is available for download and includes chromatographic data and mass spectrometry confirmation. The sample appears as a white lyophilized powder.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.